APA

Drenberg C. D., Shelat A., Dang J., Cotton A., Orwick S. J., Li M., Jeon J. Y., Fu Q., Buelow D. R., Pioso M., Hu S., Inaba H., Ribeiro R. C., Rubnitz J. E., Gruber T. A., Guy R. K. & Baker S. D. (20190607). A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML. : Nature communications.

Chicago

Drenberg Christina D, Shelat Anang, Dang Jinjun, Cotton Anitria, Orwick Shelley J, Li Mengyu, Jeon Jae Yoon, Fu Qiang, Buelow Daelynn R, Pioso Marissa, Hu Shuiying, Inaba Hiroto, Ribeiro Raul C, Rubnitz Jeffrey E, Gruber Tanja A, Guy R Kiplin and Baker Sharyn D. 20190607. A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML. : Nature communications.

Harvard

Drenberg C. D., Shelat A., Dang J., Cotton A., Orwick S. J., Li M., Jeon J. Y., Fu Q., Buelow D. R., Pioso M., Hu S., Inaba H., Ribeiro R. C., Rubnitz J. E., Gruber T. A., Guy R. K. and Baker S. D. (20190607). A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML. : Nature communications.

MLA

Drenberg Christina D, Shelat Anang, Dang Jinjun, Cotton Anitria, Orwick Shelley J, Li Mengyu, Jeon Jae Yoon, Fu Qiang, Buelow Daelynn R, Pioso Marissa, Hu Shuiying, Inaba Hiroto, Ribeiro Raul C, Rubnitz Jeffrey E, Gruber Tanja A, Guy R Kiplin and Baker Sharyn D. A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML. : Nature communications. 20190607.